Ipca Laboratories
NSEI:IPCALAB Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 7 Fair Values set on narratives written by author
WA
Consensus Narrative from 20 Analysts
Synergies With Unichem Laboratories And US Market Re-entry Will Boost Future Earnings
Key Takeaways Strong domestic formulation growth and market share improvement position Ipca Laboratories for increased revenues and earnings. Synergies with Unichem Labs and U.S. market re-entry expected to boost margins and revenue.
View narrative₹1.59k
FV
9.2% undervalued intrinsic discount11.90%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
24 days ago author updated this narrative